Replicating herpes simplex virus vectors for cancer gene therapy

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.1, Iss.4, 2000-05, pp. : 623-631

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biosafety of Gene Therapy Vectors Derived From Herpes Simplex Virus Type 1

Current Gene Therapy, Vol. 13, Iss. 6, 2013-12 ,pp. : 478-491

Bentham Science Publishers

Access to resources Recommend Favorite

Engineered herpes simplex virus vectors for antitumor therapy and vaccine delivery

By Gaston David C Whitley Richard J Parker Jacqueline N

Future Virology, Vol. 6, Iss. 3, 2011-03 ,pp. : 321-340

Future Medicine

Access to resources Recommend Favorite

Herpes Simplex Virus Vectors for Gene Delivery to a Variety of Different Cell Types

Current Gene Therapy, Vol. 2, Iss. 4, 2002-12 ,pp. : 415-426

Bentham Science Publishers

Access to resources Recommend Favorite

Non-Engineered, Naturally Oncolytic Herpes Simplex Virus HSV1 HF-10:Applications for Cancer Gene Therapy

Current Gene Therapy, Vol. 8, Iss. 3, 2008-06 ,pp. : 208-221

Bentham Science Publishers

Access to resources Recommend Favorite

Host responses to herpes simplex virus and herpes simplex virus vectors

By Hukkanen Veijo Paavilainen Henrik Mattila Riikka K

Future Virology, Vol. 5, Iss. 4, 2010-07 ,pp. : 493-512

Future Medicine

Access to resources Recommend Favorite